These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 22915616)

  • 1. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
    Palumbo-Zerr K; Horn A; Distler A; Zerr P; Dees C; Beyer C; Selvi E; Cravatt BF; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2012 Dec; 71(12):2051-4. PubMed ID: 22915616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
    Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
    Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage.
    Trabucco E; Acone G; Marenna A; Pierantoni R; Cacciola G; Chioccarelli T; Mackie K; Fasano S; Colacurci N; Meccariello R; Cobellis G; Cobellis L
    Placenta; 2009 Jun; 30(6):516-22. PubMed ID: 19419760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.
    Akhmetshina A; Dees C; Busch N; Beer J; Sarter K; Zwerina J; Zimmer A; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2009 Apr; 60(4):1129-36. PubMed ID: 19333940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Endocannabinoids in Alcohol "Binge" Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists.
    Zhou Y; Huang T; Lee F; Kreek MJ
    Alcohol Clin Exp Res; 2016 Mar; 40(3):467-73. PubMed ID: 26857901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
    Petrosino S; Di Marzo V
    Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
    Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
    Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system drives neural progenitor proliferation.
    Aguado T; Monory K; Palazuelos J; Stella N; Cravatt B; Lutz B; Marsicano G; Kokaia Z; Guzmán M; Galve-Roperh I
    FASEB J; 2005 Oct; 19(12):1704-6. PubMed ID: 16037095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis.
    Suk KT; Mederacke I; Gwak GY; Cho SW; Adeyemi A; Friedman R; Schwabe RF
    Gut; 2016 Oct; 65(10):1721-32. PubMed ID: 27196571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
    Lichtman AH; Shelton CC; Advani T; Cravatt BF
    Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes.
    Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases.
    Moreno-Martet M; Mestre L; Loría F; Guaza C; Fernández-Ruiz J; de Lago E
    Neurosci Lett; 2012 Feb; 508(2):67-72. PubMed ID: 22206832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.
    Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC
    Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral Hybrid CB
    Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R
    Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.
    Bariani MV; Domínguez Rubio AP; Cella M; Burdet J; Franchi AM; Aisemberg J
    Reproduction; 2015 Dec; 150(6):463-72. PubMed ID: 26347521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
    Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
    J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.